Multiple resistance in Gram-negative bacteria

Reviews and Research in Medical Microbiology

Volumn 15, Issue 2, 2004, Pages 51-61

  Hawkey, Peter M ^a,b   Munday, Craig J ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antibiotic resistance; Carbapenemase; Extended spectrum beta lactamase; Fluoroquinolone resistance; Integron; Plasmid

Indexed keywords

AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CEPHAMYCIN; CIPROFLOXACIN; CLAVULANIC ACID; IMIPENEM; MEROPENEM; NORFLOXACIN; QUINOLONE DERIVATIVE; SPARFLOXACIN; SULBACTAM; TAZOBACTAM;

BACTERIAL TRANSMISSION; ENTEROBACTERIACEAE; GENE POOL; GENETIC CODE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW;

EID: 3442901880     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.revmedmi.0000131427.13353.7f     Document Type: Review

References (124)

1. Anon. Vancomycin-resistant Staphylococcus aureus-Pennsylvania. MMWR 2002, 51:931.
2. Hawkey PM. Mechanisms of quinolone action and microbial responses. J Antimicrob Chemother 2003, 51 (Suppl 1):28-35.
3. Ribera A, Ruiz R, Jimenez de Anta A, Vila J. Effect of an efflux pump inhibitor on the MID of nalidixic acid for Acinetobacter baumannii and Streptrophomonas maltophilia clinical isolates. J Antimicrob Chemother 2002, 49:697-702.
4. Sykes RB, Bush K. Interaction of new cephalosporins with β-lactamases and β-lactamase producing Gram negative bacilli. Rev Infect Dis 1983, 5 (Suppl 2):S356-367.
5. Hawkey PM. The molecular evolution of antibiotic resistance in Gram negative bacteria. J Antimicrob Chemother 1986I, 18:147-149.
6. Bauernfeind A, Chong Y, Schweighart S. Extended spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989, 17:316-321.
7. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamases (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990, 34:2200-2209.
8. Horii T, Arakawa Y, Ohta M, Sugiyama T, Wacharotayankun R, Ito H, et al. Characterization of a plasmid-borne and constitutively expressed blaMOX-1 gene encoding AmpC-type beta-lactamase. Gene 1994, 139:93-98.
9. Tzouvelekis LS, Tzelepi E, Mentis AF. Nucleotide sequence of a plasmid-mediated cephalosporinase gene (blaLAT-1) found in Klebsiella pneumoniae. Antimicrob Agents Chemother 1994, 38:2207-2209.
10. Bauernfeind A, Stemplinger I, Jungwirth R, Wilhelm R, Chong Y. Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes. Antimicrob Agents Chemother 1996, 40:1926-1930.
11. Bauernfeind A, Stemplinger I, Jungwirth R, Giarmarellou H. Characterization of the plasmidic beta-lactamase CMY-2 which is responsible for cephamycin resistance. Antimicrob Agents Chemother 1996, 40:221-224.
12. Gazouli M, Tzouvelekis LS, Vatopoulos AC, Tzelepi E. Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii Amp C β-lactamase. J Antimicrob Chemother 1998, 42:419-425.
13. Yan JJ, Wu SM, Tsei SH, Wu JJ, Su JJ. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrob Agents Chemother 2000, 44:1438-1442.
14. Bauernfeind A, Stemplinger I, Jungwirth R, Giarmarellou H. Characterization of the plasmidic beta-lactamase CMY-2 which is responsible for cephamycin resistance. Antimicrob Agents Chemother 1996, 40:221-224.
15. Wu SW, Dormbusch K, Kronvall G, Norgren M. Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY type β-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii ampC β-lactamase. Antimicrob Agents Chemother 1999, 43:1350-1357.
16. Barlow M, Hall BG. Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii. Antimicrob Agents Chemother 2002, 46:1190-1198.
17. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial Agents Chemother 1995, 39:1211-1233.
18. Thomson KS, Moland ES. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrobial Agents Chemother 2001, 45:3548-3554.
19. Jacoby GA, Hau P, Alvarez M, Tenover F. Survey of extended spectrum β-lactamase (ESBL) production in US clinical isolates. 35th Interscience Conference on Antimicrob Agents Chemother. San Francisco, September 1995 [abstract C49].
20. Yan JJ, Ko WC, Tsai SH, Wu HM, Jin YT, Wu JJ. Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol 2000, 38:432-435.
21. Yan JJ, Wu SM, Tsei SH, Wu JJ, Su JJ. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan. Antimicrobial Agents Chemother 2000, 44:1438-1442.
22. M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ, Hawkey PM. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type β-lactamase exposed during an outbreak of SHV-5 extended-spectrum β-lactamase in a Leeds hospital. J Antimicrobial Chemother 1997, 40:823-831.
23. Winokur PL, Vonstein DL, Hoffman E, Uhlenhopp K, Doern GV. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrobial Agents Chemother 2001, 45:2716-2722.
24. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
25. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedmann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985, 28:302-307.
26. Barthelemy M, Peduzzi J, Yaghlane BH, Labia R. Single amino acid substitution between SHV-1 β-lactamase and cefotaxime-hydrolysing SHV-2 enzymes. FEBS Letters 1988, 231:217-220.
27. Arpin C, Labia R, Andre C, Frigo C, El Harrif Z, Quentin C. SHV-16, a β-lactamase with a pentapeptide duplication in the omega loop. Antimicrobial Agents Chemother 2001, 45:2480-2485.
28. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistant threat. Clin Microbiology Rev 2001, 14: 933-951.
29. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistant threat. Clin Microbiol Rev 2001, 14:933-951.
30. Smith Moland E, Black JA, Ourada J, Reisbig MD, Handson ND, Thomas KS. Occurrence of newer b-lactamases in Klebsiella pneumoniae isolates from 24 U.S hospitals. Antimicrob Agents Chemother 2002, 46:3837-3842.
31. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1998, 18:294-298.
32. Barthelemy M, Peduzzi J, Bernard H, Tancrede C, Labia R. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta 1992, 1122:15-22.
33. Smith Moland E, Black JA, Hossain A, et al. Discovery of CTX-M-Like extended-spectrum b-lactamases in Escherichia coli isolates from five U.S States. Antimicrob Agents Chemother 2003, 47:2382-2383.
34. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000, 14:137-142.
35. Decousser JW, Poirel L, Nordmann P. Characterization of a chromosomally encoded extended-spectrum class A beta-lactamase from Kluyvera cryocrescens. Antimicrob Agents Chemother 2001, 45:3595-3598.
36. Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A. Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother 2002, 46:3045-3049.
37. Humeniuk C, Arlet G, Gautier V, Grimont P, Labia R, Philippon A. Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother 2002, 46:3045-3049.
38. Poirel L, Naas T, Le Thomas I, Karim A, Bingen E, Nordmann P. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother 2001, 45:3355-3361.
39. Brenwald NP, Jevons G, Andrews JM, Xiong JH, Hawkey PM, Wise R. An outbreak of CTX-M-type B-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum B-lactamases. J Antimicrob Chemother 2003, 51:195-196.
40. Ma L, Ishii Y, Ishiguro M, Matsuzawa H, Yamaguchi K. Cloning and sequencing of the gene encoding Toho-2, a class A beta-lactamase preferentially inhibited by tazobactam. Antimicrob Agents Chemother 1998, 42:1181-1186.
41. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000, 14:137-142.
42. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988, 10:867-878.
43. M'Zali FH, Chanawong A, Kerr KG, Birkenhead D, Hawkey PM. Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL. J Antimicrob Chemother 2000, 45:881-885.
44. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ. CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 2000, 14:137-142.
45. Bonnet R, Sampaio JL, Labia R, De Champs C, Sirot D, Chanal C, et al. A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother. 2000, 44:1936-1942.
46. Bradford PA, Yang Y, Sahm D, Grope I, Gardovska D, Storch G. CTX-M-5, a novel cefotaxime-hydrolyzing β-lactamase from an outbreak of Salmonella typhimurium in Latvia. Antimicrob Agents Chemother 1998, 42:1980-1984.
47. Gazouli M, Sidorenko SV, Tzelepi E, Kozlova NS, Gladin DP, Tzouvelekis LS. A plasmid-mediated beta-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia. J Antimicrob Chemother 1998, 41:119-121.
48. Tassios PT, Gazouli M, Tzelepi E, Milch H, Kozlova N, Sidorenko S, et al. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J Clin Microbiol 1999, 37:3774-3777.
49. Gniadkowski M, Schneider I, Palucha A, Jungwirth R, Mikiewicz B, Bauernfeind A. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 1998, 42:827-832.
50. Baraniak A, Fiett J, Sulikowska A, Hryniewicz W, Gniadkowski M. Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 2002, 46: 151-159.
51. Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J Antimicrob Chemother 2002, 50: 393-396.
52. Ishii Y, Ohno A, Taguchi H, Imajo S, Ishiguro M, Matsuzawa H. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 1995, 39:2269-2275.
53. Yagi T, Kurokawa H, Shibata N, Shibayama K, Arakawa Y. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 2000, 184:53-56.
54. Chanawong A, M'Zali FH, Heritage J, Xiong JH, Hawkey PM. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX.M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 2002, 46:630-637.
55. GenBank No. AF462635, GenBank No. AY005110.
56. Radice M, Power P, Di Conza J, Gutkind G. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 2002, 46:602-604.
57. Paterson DL, Hujer KM, Hujer AM, Rice LB, Bonomo RA. Extended spectrum beta-lactamases (ESBLs) in bloodstream isolates worldwide: dominance of SHV type beta-lactamases and widespread prevalence of CTX-M type enzymes. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, September 2002 [abstract C2-1868].
58. Smith-Moland E, Pottumarthy-Boddu S, Black JA, Hossain A, Hanson ND, Thomson KS. Discovery of CTX-M-like ESBLs in E.coli isolates form five states from the USA. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 2002 [abstract LB-13].
59. Arakawa Y, Murakami M, Suzuki K, Ito R, Wacharotayankun R, Ohsuka S, et al. A novel integron-like element carrying the metallo-β-lactamase gene blaIMP. Antimicrob Agents Chemother 1995, 39:1612-1615.
60. Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, et al. Cloning and characterization of blaVIM a new integron borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999, 43:1584-1590.
61. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J-D, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000, 44:891-897.
62. Riccio M, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, et al. Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother 2000, 44:1229-1235.
63. Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases. Antimicrob Agents Chemother 1997, 41:223-232.
64. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001, 45:1151-1161.
65. Poirel L, Naas T, Le Thomas I, Karim A, Bingen, E, Nordmann P. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob Agents Chemother 2001, 45:3355-3361.
66. Avison M.B, Higgins CS, von Heldreich CJ, Bennett P, Walsh TR. Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 2001, 45:413-419.
67. Chu Y-W, Afzal-Shah M, Houang ETS, Palepou M-FI, Lyon DJ, Woodford N, et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 2001, 45: 710-714.
68. Perez AN, Bonnet IG, Robledo EH, Abascal RD, Plous CV. Metallo-β-lactamases in Acinetobacter calcoaceticus? Med Sci Res 1996, 24:315-317.
69. Cornaglia G, Riccio ML, Mazzariol A, Lauretti L, Fontana R, Rossolini GM. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 1999, 353:899-900.
70. Takahashi A, Yomoda S, Kobayashi I, Okubo T, Tsunoda M, Iyobe S. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J Clin Microbiol 2000, 38:526-529.
71. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002, 8:321-331.
72. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, et al. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 1994, 38:71-78.
73. Senda K, Arakawa Y, Ichiyama S, Nakashima K, Ito H, Ohsuka S, et al. PCR detection of metallo-β-lactamase gene (blaIMP) in gram-negative rods resistant to broad spectrum β-lactams. J Clin Microbiol 1996, 34:2909-2913.
74. Senda K, Arakawa Y, Nakashima K, Ito H, Ichiyama S, Shimokata K, et al. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams including carbapenems. Antimicrob Agents Chemother 1996, 40:349-353.
75. Koh TH, Babini GS, Woodford N, Sng LH, Hall LMC, Livermore D. Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore. Lancet 1999, 353:2162.
76. Iyobe S, Kusadokoro H, Ozaki J, Matsumura N, Minami S, Haruta S, et al. Amino acid substitutions in a variant of IMP-1 metallo-β-lactamase. Antimicrob Agents Chemother 2000, 44:2023-2027.
77. Hawkey PM, Xiong J, Ye H, Li H, M'Zali FH. Occurrence of a new metallo-β-lactamase IMP-4 carried on a conjugative plasmid in Citrobacter youngae from the People's Republic of China. FEMS Microbiology Letters 2001, 194:53-57.
78. Gibb AP, Tribuddharat C, Moore RA, Louie TJ, Krulicki W, Livermore DM, Palepou MI, Woodford N. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP Allele, blaIMP-7. Antimicrob Agents Chemother 2002, 46:255-258.
79. Yan JJ, Ko WC, Chuang CL, Wu JJ. Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP+8 in Enterobacter clocae and first identification of VIM-2 Citrobacter freundii. J Antimicrob Chemothe 2002, 50:503-511.
80. Lee K, Lim JB, Yum JH, Yong D, Chong Y, Kim JM, Livermore DM. blaVIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother 2002, 46:1053-1058.
81. Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M. Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001, 45:1343-1348.
82. Emmerson AM, Jones AM. The quinolones: decades of development and use. J Antimicrob Chemother 2003, 51 (Suppl S1): 13-20.
83. Hoshino K, Kitamura A, Morrissey I, Sato K, Kato J, Ikeda H. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob Agents Chemother 1994, 38:2623-2627.
84. Khodursky AB, Zechiedrich EL, Cozzarelli NR. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci USA 1995, 92:11801-11805.
85. Pan XS, Fisher LM. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother 1997, 41:471-474.
86. Pan XS, Yague G, Fisher LM. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins. Antimicrob Agents Chemother 2001, 45:3140-3147.
87. Oizumi N, Kawabata S, Hirao M, Watanabe K, Okuno S, Fujiwara T, et al. Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus. J Infect Chemother 2001, 7:191-194.
88. Wetzstein HG, Schmeer N, Karl W. Degradation of the flouroquinolone enrofloxacin by the brown rot fungus Gloeophylum straitum: Identification of metabolites. Appl Environ Microbiol 1997, 63:4272-4281.
89. Martinez-Martinez L, Pascual A, Jacoby GA Quinolone resistance from a transferabe plasmid. Lancet 1998, 351:797-799.
90. Tran JH, Jacoby GA. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci USA 2002, 99:5638-5642.
91. Jacoby GA, Chow N, Waites KB. Prevalence of plasmid mediated quinolone resistance. Antimicrob Agents Chemother 2003, 47:559-562.
92. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper D. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai China. Antimicrob Agents Chemother 2003, 47:2242-2248.
93. Nikaido H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin Infect Dis 1998, 27 (Suppl 1):S32-S41.
94. Li XZ, Livermore DM, Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother 1994, 38:1732-1741.
95. Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993, 175:7363-7372.
96. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol 1993, 175:6299-6313.
97. Murakami S, Nakashima R, Yamashita E, Yamaguchi A. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 2002, 419:587-593.
98. Zgurskaya HI, Nikaido H. Multidrug resistance mechanisms: drug efflux across two membranes. Microbiology 2000, 37: 219-225.
99. Kohler T, Michea-Hamzehpour M, Plesiat P, Kahr AL, Pechere JC. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997, 41:2540-2543.
100. O'Brien TF, Ross DG, Guzman MA, Medeiros AA, Hedges RW, Botstein D. Dissemination of an antibiotic resistance plasmid in hospital patient flora. Antimicrob Agents Chemother 1980, 4:537-543.
101. Enn VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in UK despite national prescribing restrictions. Lancet 2001, 357:1325-1328.
102. Hibbert-Rogers LC, Heritage J, Gascoyne-Binzi DM, Hawkey PM, Todd N, Bailey C. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. J Antimicrob Chemother 1995, 36:65-82.
103. Marchandin H, Carriere C, Sirot D, Jean-Pierre H, Darbas H. TEM-24 Produced by four different species of Enterobacteriaceae, including Providencia retgeri, in a single patient. Antimicrob Agents Chemother 1999, 43:2069-2073.
104. Shirley M, Gordon D M, Collingnon PJ. Species differences in plasmid carriage in the Enterobacteriaceae. Plasmid 2003, 49:79-85.
105. Bennett PM, Hawkey PM. The future contribution of transportation to antimicrobial resistance. J Hosp Infect 1991, 18:211-221.
106. Hall RM, Collins CM. Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons. Drug Resist Update 1998, 1:109-119.
107. Cross AS, Opal S, Kopecko DJ. Progressive increase in antibiotic resistance of Gram-negative Bacterial Isolates. Walter Reed Hospital, 1976-1980: specific analysis of gentamicin, tobramycin and amikacin resistance. Arch Intern Med 1983, 143: 2075-2080.
108. Holmberg S, Solomon S, Blake P. Health and economic impact of antimicrobial resistance. Rev Infect Dis 1987, 9:1065-1078.
109. Cohen ML. Epidemology of drug resistance: implications for a post anti-microbial era. Science 1992, 257:1050-1055.
110. Martinez-Freijo P, Fluit AC, Schmitz FJ, Grek VSC, Verhoef J, Jones ME. Class 1 integrons in gram-negative isolates from different European hospitals and associations with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 1998, 42:689-696.
111. Fluit AC, Schmitz FJ. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur J Clin Microbiol Infect Dis 1999, 18: 761-770.
112. Leverstein-van Hall MA, Blok HEM, Rogier A, Donders T, Paauw A, Fluit C, Verhoef J. Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species of isolate origin. J Infect Dis 2003, 187:
113. Bush K, Jacoby GA, Medeiros A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 39:1211-1233.
114. Monnet DL, Biddle JW, Edwards JR, et al. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol 1997, 18:492-498.
115. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporins use to control total cephalosporins resistance in nosocomial Klebsiella. JAMA 1998, 280:1233-1237.
116. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G, and the Italian ESBL Study Group. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 2002, 46:196-202.
117. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsielle pneumoniae. Infect Control Hosp Epidemiol 2000, 21:455-458.
118. Monnet DL, Biddle JW, Edwards JR, Culver DH, Tolson JS, Martone WJ, et al. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol 1997, 18:492-498.
119. Rahal JJ, Urban C, Horn D, Freeman K, Culver DH, Tolson JS, et al. Class restriction of cephalosporins use to control total cephalosporins resistance in nosocomial Klebsiella. JAMA 1998, 280:1233-1237.
120. Rice LB, Eckstein EC, DeVente J, Sh;aes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996, 23:118-124.
121. Lepper PM, Grusa E, Reichl H, Hogel J, Trautmann M. Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002, 46:2920-2925.
122. Da Silva GJ, Correia M, Vital C, et al. Molecular characterization of bla (IMP-5), a new integron-bo metallo-beta-lactamase gene from an Ancinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett 2002, 215:33-39.
123. Toleman MA, Simm AM, Murphy TA, et al. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated from Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother, 2002, 50:673-679.
124. Stapleton PD, Shannon KP, French GL. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4-β-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999, 43:1206-1210.